Creative Medical Technology Holdings, Inc. ( CELZ) - Key Metrics
CELZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.41 | -$0.40 | -$0.40 |
| 2026Q1 | $0 | -$0.38 | -$0.36 | -$0.36 |
| 2025Q4 | $0 | -$0.79 | -$0.81 | -$0.81 |
| 2025Q3 | $0 | -$0.48 | -$0.45 | -$0.45 |
| 2025Q2 | $0 | -$0.48 | -$0.45 | -$0.45 |
CELZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.88 |
| 2026Q1 | 0% | -1.36 |
| 2025Q4 | 0% | -0.67 |
| 2025Q3 | 0% | -1.73 |
| 2025Q2 | 0% | -1.38 |
CELZ
Price: $0.80
52 week price:
Earnings Per Share: -2.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 183800
Market Capitalization: 2.4 million